Deep learning of cell spatial organizations identifies clinically relevant insights in tissue images.

Journal: Nature communications
Published Date:

Abstract

Recent advancements in tissue imaging techniques have facilitated the visualization and identification of various cell types within physiological and pathological contexts. Despite the emergence of cell-cell interaction studies, there is a lack of methods for evaluating individual spatial interactions. In this study, we introduce Ceograph, a cell spatial organization-based graph convolutional network designed to analyze cell spatial organization (for example,. the cell spatial distribution, morphology, proximity, and interactions) derived from pathology images. Ceograph identifies key cell spatial organization features by accurately predicting their influence on patient clinical outcomes. In patients with oral potentially malignant disorders, our model highlights reduced structural concordance and increased closeness in epithelial substrata as driving features for an elevated risk of malignant transformation. In lung cancer patients, Ceograph detects elongated tumor nuclei and diminished stroma-stroma closeness as biomarkers for insensitivity to EGFR tyrosine kinase inhibitors. With its potential to predict various clinical outcomes, Ceograph offers a deeper understanding of biological processes and supports the development of personalized therapeutic strategies.

Authors

  • Shidan Wang
    Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, 5325 Harry Hines Blvd, Dallas, TX, 75390, USA.
  • Ruichen Rong
    Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Qin Zhou
    The Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China.
  • Donghan M Yang
    Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Xinyi Zhang
    Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Xiaowei Zhan
    Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: xiaowei.zhan@utsouthwestern.edu.
  • Justin Bishop
    Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Zhikai Chi
    Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Clare J Wilhelm
    Department of Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Siyuan Zhang
    Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block, Level 11, Singapore, 119228, Singapore.
  • Curtis R Pickering
    Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
  • Mark G Kris
    Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • John Minna
    Hamon Center for Therapeutic Oncology Research, Department of Internal Medicine and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
  • Yang Xie
    Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, 5325 Harry Hines Blvd, Dallas, TX, 75390, USA.
  • Guanghua Xiao